Comparison of low and medium energy of extracorporeal shock wave therapy for a short-term improvement of carpal tunnel syndrome: a double-blinded randomized, controlled study.

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

TCTR

Registry ID

TCTR20210310001

Enrollment

Registered

2021-03-10

Start date

2021-04-01

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The patient who had a diagnosis of CTS with mild or moderate degree Carpal tunnel syndrome CTS Extracorporeal shock wave therapy ESWT low energy medium energy visual analogue scale VAS Boston Carpal Tunnel Syndrome Questionnaire BCTQ median nerve

Interventions

Radial extracorporeal shock wave therapy

BTL-6000 SWT, 9 mm. multifocal at the carpal tunnel area medium energy: Intensity 4 bar, total 2000 shots per session, 1 session per week, total 3 sessions, frequency 5 Hz,Radial extracorporeal shock

BTL-6000 SWT, 9 mm. multifocal at the carpal tunnel area low energy: Intensity 2 bar, total 2000 shots per session, 1 session per week, total 3 sessions, frequency 5 Hz

Active Comparator Device,Active Comparator Device

medium energy radial extracorporeal shock wave therapy,low energy radial extracorporeal shock wave therapy

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patient who had a diagnosis of CTS with mild or moderate degree - Mild degree: delayed peak sensory distal latency, normal SNAP amplitude, normal distal motor latency, and normal CMAP amplitude - Moderate degree: delayed peak sensory distal latency, small SNAP amplitude, delayed Distal motor latency, normal CMAP amplitude - If the patient has clinical bilaterally, the more severe site will be chosen 2. Patient with CTS symptoms which never undergone any treatment 3. Age 18 to 65 years 4. Able to communicate and read in Thai

Exclusion criteria

Exclusion criteria: 1. Patients who had conditions mimicking CTS such as cervical radiculopathy, polyneuropathy, brachial plexopathy, stroke, or spinal cord injury 2. Patients with a history of the distal forearm or wrist fracture and recent wrist or arm trauma 3. Contraindication to ESWT: bleeding disorder and pregnancy 4. Contraindication to electrodiagnostic study: on external wires like external pacing wires or guidewires 5. Participate in two or more trial at the same time

Design outcomes

Primary

Measure	Time frame
Visual analogue scale (VAS) of numbness baseline, 1, 4, 8, 12 weeks after the first session of treatmment Visual analogue scale	—

Secondary

Measure	Time frame
Boston Carpal Tunnel Syndrome Questionnaire (BCTQ) baseline, 1, 4, 8, 12 weeks after the first session of treatmment Boston Carpal Tunnel Syndrome Questionnaire,Electrodiagnostic parameters at 12 weeks after the first session of treatmment electrodiagnostic parameter of median nerve at wrist level,Patient satisfaction at 1, 4, 8, 12 weeks after the first session of treatmment Patient satisfaction scale (5-point Likert scale)	—

Measure

Time frame

Boston Carpal Tunnel Syndrome Questionnaire (BCTQ) baseline, 1, 4, 8, 12 weeks after the first session of treatmment Boston Carpal Tunnel Syndrome Questionnaire,Electrodiagnostic parameters at 12 weeks after the first session of treatmment electrodiagnostic parameter of median nerve at wrist level,Patient satisfaction at 1, 4, 8, 12 weeks after the first session of treatmment Patient satisfaction scale (5-point Likert scale)

—

Countries

Thailand

Contacts

Public ContactTulaya Dissaneewate

Prince of Songkla University

tulaya.p@psu.ac.th074451601

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Apr 4, 2026